Mounjaro®
Starting from £179.99/mo
Start journey Learn moreA raised temperature while taking Mounjaro (tirzepatide) can have several causes, and working out which one applies to you matters. Fever itself is not listed as a common side effect of tirzepatide, so if you develop one, it usually points to something else — an infection, a reaction, or occasionally a complication worth ruling out. Here is what the clinical picture looks like, and when to act. As a prescription-only medicine, Mounjaro is dispensed following a personal clinical assessment; any new or concerning symptoms during treatment should be discussed with your prescriber or a healthcare professional promptly.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The first thing to do is locate the problem. Injection-site reactions (a patch of redness, warmth, or mild swelling at the spot where you injected) are common and well-documented with tirzepatide. They tend to appear within a few hours and settle on their own within a day or two. That localised warmth is not the same as a fever. You can check by taking your temperature with a thermometer: a reading of 38°C or above signals a systemic response, not just skin irritation.
If your thermometer reads normal but the injection area is uncomfortable, you are most likely dealing with a local reaction. Rotating your injection sites (abdomen, thigh, and upper arm are all licensed locations) helps reduce how often this happens. The NHS tirzepatide page covers injection-site reactions in its side-effect section and is worth bookmarking for exactly these moments. Swapping to a fresh needle for each dose also matters more than people realise.
If your temperature is genuinely elevated, move to step two.
Tirzepatide does not appear to suppress immunity, but people on any weight-management programme can pick up the usual seasonal bugs. A cold, flu, urinary tract infection, or similar will raise your temperature regardless of what else you are taking. The complication with GLP-1 treatment is what illness does to your hydration. Mounjaro already slows gastric emptying, which affects how quickly fluids move through your system. Add vomiting or diarrhoea from a virus and dehydration can set in faster than you might expect.
The practical priority during any febrile illness on Mounjaro is fluid intake: small, frequent sips rather than large volumes at once. If you cannot keep fluids down for more than a few hours, that warrants a call to 111 or your GP, not a wait-and-see. Our guide to tirzepatide fever has more on how the medicine affects your digestive system during illness.
Consult your prescriber or Patient Information Leaflet about whether to delay your weekly injection if you are acutely unwell. Timing decisions like that belong with a clinician, not a forum post.
Two scenarios involving fever on Mounjaro should prompt same-day or emergency care rather than a scheduled call. The first is acute pancreatitis. In January 2026, the MHRA issued a Drug Safety Update specifically flagging pancreatitis as an infrequent but serious risk with GLP-1 receptor agonists. The symptom pattern is severe, persistent pain in the upper abdomen that may radiate to the back, sometimes accompanied by vomiting and, in some cases, fever. If that description fits what you are experiencing, seek urgent medical help.
The second scenario is a rapidly worsening injection-site reaction: spreading redness, significant swelling beyond the immediate injection area, increasing heat, or the area feeling hard to the touch. These can occasionally signal a more serious skin infection. Again, do not put it off until morning if you are genuinely concerned. A nurse or GP can assess it quickly.
For everything less dramatic (a temperature of 38–38.5°C, a clear viral cause, no abdominal pain) manage the infection, stay hydrated, and let your prescriber know at your next contact. If you are mid-titration and wondering whether to delay your dose increase, that is a reasonable question to raise; many patients do exactly that, and decisions about pausing or adjusting Mounjaro should always involve your prescriber rather than a self-directed stop.
Any symptom that causes you to seek medical attention during Mounjaro treatment is worth documenting: the date, your temperature reading, how long it lasted, what you took for it, and how it resolved. This kind of note is genuinely useful at your next clinical review. It helps your prescriber spot patterns, and it gives them the full picture if a dose change is being considered.
Fever during hay fever season is a specific question some patients raise, a raised temperature is not a hallmark of hay fever, but the timing can cause confusion. There is a dedicated page on Mounjaro and hay fever that separates the two clearly if that is the overlap you are dealing with. Similarly, if this is a broader question about how long you might be on tirzepatide, our page on whether you can stay on Mounjaro forever is worth reading ahead of your review, and we also have dedicated pages covering whether you can take Mounjaro forever and whether you have to take Mounjaro forever, which many patients find useful when thinking through their long-term options with their prescriber.
Mounjaro is dispensed through a structured clinical process that includes a prescriber review before every order, so there is always a route to flag new symptoms without waiting for a formal GP appointment. Speak to our prescribers if you are uncertain about anything that has come up since your last review.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.